Attention Deficit Hyperactivity Disorder (ADHD) - Drug Pipeline Analysis and Market Forecasts to 2015
Posted Apr 19 2010 12:44am
The industry analysis specialist’s new report, “Attention Deficit Hyperactivity Disorder – Drug Pipeline Analysis and Market Forecasts to 2015” is an essential source of information and analysis on the global ADHD market. The report identifies the key trends shaping and driving the dynamism in the global ADHD market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global ADHD sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by our research team of industry experts. Scope
The scope of the report includes: - Annualized global ADHD market revenues data from 2000 to 2008, forecast forward for 7 years to 2015. - Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan. - Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include triple reuptake inhibitors, GABA receptor modulators, acetylcholine receptor agonists, AMPA receptor modulators, serotonin receptor targettors, selective histamine antagonists, norepinephrine reuptake inhibitors and alpha-2 adrenergic agonists - Analysis of the current and future market competition in the global ADHD market. Each trend is independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends. - Insightful review of the future market players, key industry drivers, restraints and challenges which are likely to impact the ADHD therapeutics market in the long run. Key future market players covered are Addrenex, Abbott Laboratories, Psychogenics, AstraZeneca and Cortex. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with ADHD.